| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.51 | 0.0004 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.84 | 0.0006 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.0009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |